✦ LIBER ✦

The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms

✍ Scribed by Jew Win Kuan; Kian Meng Chang; Ngee Siang Lau; Purushothaman Visalachy; Sen Mui Tan; Tee Chuan Ong; Anselm Ting Su

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guidelines for the management of mature

✍ Claire E. Dearden; Rod Johnson; Ruth Pettengell; Stephen Devereux; Kate Cwynarsk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Overview of alemtuzumab therapy for the

✍ Zinzani, Pier Luigi; Corradini, Paolo; Gallamini, Andrea; Grossi, Alberto; Lazza 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 284 KB

Alemtuzumab shows promise for the treatm

✍ McNeely, Wendy 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 149 KB

Commentary on the 2008 WHO classificatio

✍ Megan S. Lim; Laurence de Leval; Leticia Quintanilla-Martinez 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 148 KB

Phase I trial of bortezomib in combinati

✍ Jorge E. Romaguera; Luis E. Fayad; Peter McLaughlin; Barbara Pro; Alma Rodriguez 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Assembly of the immunological synapse fo

✍ Daniel M Davis 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 468 KB